WATERS CORP /DE/ (WAT)
Health Care / Life Sciences Tools & Services
S&P 500$299.93
Scores poorly across most models. Proceed with caution.
Weak
Score based on 5 of 5 models — high confidence
Is WATERS CORP /DE/ a Good Investment in 2026?
WATERS CORP /DE/ (WAT) scores 3.8 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model is the most favorable, rating WATERS CORP /DE/ as Neutral. However, the Graham model rates it Caution — 41% above fair value. WATERS CORP /DE/ currently trades above its estimated fair value of $263, suggesting limited upside at current prices. WATERS CORP /DE/ ranks #875 out of 1127 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Trading slightly above estimated fair value.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Neutral
4/9
Buffett
Neutral
Business quality & competitive moat
Graham
Caution
41% above fair value
Lynch
Neutral
PEG 3.1 · Stalwart
Greenblatt
Neutral
Top 25% (rank 21%)
Frequently Asked Questions
Is WATERS CORP /DE/ (WAT) a good investment?
What is WATERS CORP /DE/'s Piotroski F-Score?
Is WAT overvalued or undervalued?
How does WAT compare to other Health Care stocks?
What do investment models say about WAT?
Similar Stocks
Compare WAT with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer